Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPCMetastatic Castration-resistant Prostate Cancer (mCRPC)RecruitingPhase 22025-08-27NCT06241846

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
MediLink Therapeutics (Suzhou) Co., Ltd.24

24 results · Page 1 of 1

Swipe the table sideways for more columns.